| 151 |
21756359 | Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registry. | 2011 Jul 14 |
1 |
| 152 |
20402634 | Saxagliptin: a new drug for the treatment of type 2 diabetes. | 2010 Jul |
1 |
| 153 |
20462426 | Rhinorrhea, cough and fatigue in patients taking sitagliptin. | 2010 May 12 |
2 |
| 154 |
20690781 | Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions. | 2010 Sep |
2 |
| 155 |
20707611 | Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin. | 2010 Oct |
1 |
| 156 |
20824678 | Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus. | 2010 Oct |
1 |
| 157 |
20876838 | Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs. | 2010 Sep |
1 |
| 158 |
21189532 | [Medication of the month. Sitagliptin-metformin fixed combination (Janumet)]. | 2010 Nov |
1 |
| 159 |
21335294 | Treatment of elderly patients with type 2 diabetes mellitus: a systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitors. | 2010 Oct |
1 |
| 160 |
21437102 | Saxagliptin for type 2 diabetes. | 2010 Sep 22 |
1 |
| 161 |
21537433 | Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes. | 2010 Jul 15 |
2 |
| 162 |
19538242 | Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes. | 2009 Jun |
5 |
| 163 |
19900194 | New developments in incretin-based therapies: the current state of the field. | 2009 Nov |
1 |
| 164 |
20213998 | Differential expression of dipeptidyl peptidase-IV (DPP-IV) in Indian type-2 diabetic population. | 2009 Sep |
1 |
| 165 |
18171434 | Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs. | 2008 Jan |
1 |
| 166 |
18333888 | The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus. | 2008 Apr |
2 |
| 167 |
17559747 | A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies. | 2007 Jul |
2 |
| 168 |
17655515 | Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus. | 2007 Aug |
1 |
| 169 |
18054733 | DPP-4 inhibitors. | 2007 Dec |
1 |
| 170 |
18217246 | Clinical management strategies for type 2 diabetes. | 2007 Dec |
1 |
| 171 |
16242377 | Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes. | 2006 |
1 |
| 172 |
15842525 | Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes. | 2005 May |
5 |
| 173 |
16043735 | Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. | 2005 Aug |
2 |
| 174 |
15562200 | Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. | 2004 Dec |
2 |
| 175 |
11883961 | Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1. | 2002 Mar 15 |
4 |
| 176 |
11289473 | Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects. | 2001 Mar |
1 |